A Nashville Medication Error Left Patients Paralyzed—and Fueled a Second, Unfounded Controversy

A Nashville Medication Error Left Patients Paralyzed—and Fueled a Second, Unfounded Controversy
A routine joint-replacement procedure in Nashville became a medical crisis after four patients were reportedly injected with potassium phosphate instead of anesthetic. At least two patients were paralyzed, while state investigators examine how the medication error occurred.

Ascension Saint Thomas Midtown Hospital acknowledged the pharmacy mistake and said patients suffered “adverse health reactions.” The Tennessee Bureau of Investigation confirmed that it is investigating after receiving information from state health regulators. The account presented by the conservative-leaning report centers on the patients and their families, including Kristina Dorton, whose mother-in-law reportedly lost sensation from the breastbone down. “The joint replacement went wonderful. Her knee is great. The rest of her is not,” Dorton said.

Hospital President and CEO Dr. Shubhada Jagasia apologized, saying leadership had met with the families, reported the incident to regulators and introduced additional safeguards. The hospital said it had identified the cause and launched enhanced safety protocols. That response contrasts with the family’s account that treatment was not restoring movement and that “time is of the essence.”

The liberal-leaning article also highlights the public anger surrounding the incident, but much of its focus shifts from pharmacy procedures to Jagasia’s Indian background and medical education. It acknowledges that there is “no evidence” those factors contributed to the error. Social-media reactions quoted in the article nevertheless promote explicitly xenophobic claims and speculation about her credentials—allegations unsupported by the reported facts. The documented issue is a hospital medication failure, not the nationality or education of its chief executive. Accountability will depend on investigators establishing how the drug was selected, prepared and administered, and whether safeguards failed at multiple points.